Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123161 · ClinicalTrials.gov registry record · Phase 2
The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
A Phase 2 study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT01123161 is a Phase 2 study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 120 participants.
The verdict
NCT01123161, a Phase 2 study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine whether the combination of thrombolysis and hypothermia is superior to thrombolysis alone for the treatment of acute ischemic stroke.
Interventions
- DEVICE hypothermia and anti-shivering treatment
- DRUG Group1: IV t-PA and normothermia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2010-06 |
| Est. Completion | 2015-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01123161
The ClinicalTrials.gov registry entry for NCT01123161 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which hypothermia and anti-shivering treatment is the first listed.
NCT01123161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01123161 about?
NCT01123161 is a clinical study titled "The Intravascular Cooling in the Treatment of Stroke 2/3 Trial". The purpose of this trial is to determine whether the combination of thrombolysis and hypothermia is superior to thrombolysis alone for the treatment of acute ischemic stroke.
What is the current status of trial NCT01123161?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2010-06. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01123161?
The interventions under investigation include: hypothermia and anti-shivering treatment (DEVICE), Group1: IV t-PA and normothermia (DRUG).
Who is sponsoring clinical trial NCT01123161?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.